Parker-Hannifin Corporation (PH) Business News

Track Parker-Hannifin Corporation in real time with a live news feed covering Parker-Hannifin Corporation stock news, official press releases, company announcements, and an archive of historical Parker-Hannifin Corporation news. ...more

  • Calendar
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection

Parker to Acquire CIRCOR's Commercial and Defense Aerospace Business

GlobeNewsWire

9:20 AM | Thursday | May 21, 2026

news photo
Loading...

CLEVELAND, May 21, 2026 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE:PH), the global leader in motion and control technologies, today announced that it has entered into a definitive agreement to acquire the Commercial and Defense Aerospace business of CIRCOR International, Inc. on a cash-free, debt-free basis for a cash purchase price of $2.55 billion, which includes expected tax benefits with an estimated net present value of approximately $75 million. The purchase price, net of expected tax benefits, represents 22.7x CIRCOR Aerospace's calendar year 2026 estimated adjusted EBITDA, or 18.
2x including expected cost synergies of approximately 10% of calendar year 2026 estimated sales. The transaction is subject to customary closing conditions, including receipt of applicable regulatory approvals, and is expected to close in the second half of calendar year 2026.

Read full article redirect
9:20 AM | Thursday | May 21, 2026

Parker to Acquire CIRCOR's Commercial and Defense Aerospace Business

GlobeNewsWire

CLEVELAND, May 21, 2026 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE:PH), the global leader in motion and control technologies, today announced that it has entered into a definitive agreement to acquire the Commercial and Defense Aerospace business of CIRCOR International, Inc. on a cash-free, debt-free basis for a cash purchase price of $2.55 billion, which includes expected tax benefits with an estimated net present value of approximately $75 million. The purchase price, net of expected tax benefits, represents 22.7x CIRCOR Aerospace's calendar year 2026 estimated adjusted EBITDA, or 18.
2x including expected cost synergies of approximately 10% of calendar year 2026 estimated sales. The transaction is subject to customary closing conditions, including receipt of applicable regulatory approvals, and is expected to close in the second half of calendar year 2026.

Read full article arrow
News Thumbnail
9:15 AM | Thursday | May 21, 2026

KKR Sells CIRCOR Aerospace to Parker Hannifin for $2.55 Billion

Business Wire

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--KKR and CIRCOR International (“CIRCOR” or the “Company”), a global manufacturer of flow control products for industrial, naval, and aerospace markets, today announced the signing of a definitive agreement to sell CIRCOR Aerospace, the Company's aerospace division, to Parker Hannifin Corporation (NYSE:PH), the global leader in motion and control technologies, for $2.55 billion. Funds managed by KKR first acquired CIRCOR for $1.8 billion in 2023 and.

Read full article arrow
News Thumbnail
7:30 AM | Thursday | Apr 30, 2026

Parker Reports Fiscal 2026 Third Quarter Results

GlobeNewsWire

CLEVELAND, April 30, 2026 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today reported results for the quarter ended March 31, 2026, that included the following highlights (compared with the prior year period): Fiscal 2026 Third Quarter Highlights: Sales increased 11% to a record $5.5 billion; organic sales increased 6.5% Segment operating margin was 23.4%, an increase of 20 bps, or 26.7% adjusted, an increase of 40 bps Net income was $0.
9 billion, a decrease of 6% compared with the third quarter of fiscal 2025 which included a one-time discrete tax benefit of $180 million Adjusted net income increased 16% to $1.0 billion EPS were $7.06, a decrease of 4% compared with the third quarter of fiscal 2025 which included a one-time... Read more

Read full article arrow
News Thumbnail
5:00 PM | Tuesday | Apr 14, 2026

Parker to Announce Fiscal 2026 Third Quarter Earnings on April 30; Conference Call and Webcast Scheduled for 11 a.m. Eastern

GlobeNewsWire

CLEVELAND, April 14, 2026 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that it will release its fiscal 2026 third quarter earnings before the market opens on Thursday, April 30, 2026, followed by a conference call at 11:00 a.m., Eastern time.

Read full article arrow
News Thumbnail
5:00 PM | Thursday | Mar 12, 2026

Parker Scheduled to Present at the Bank of America Global Industrials Conference on March 18 at 10:30 a.m. Greenwich Mean Time (6:30 a.m.

GlobeNewsWire

CLEVELAND, March 12, 2026 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that it is scheduled to present at the Bank of America Global Industrials Conference in London, England on March 18, 2026 at 10:30 a.m. Greenwich Mean Time (6:30 a.m. Eastern Time).
A live webcast of the presentation will be accessible on Parker's investor information website at investors.parker.com and will be archived on the site.

Read full article arrow
News Thumbnail
2:00 AM | Wednesday | Feb 25, 2026

35Pharma to be Acquired by GSK to Accelerate Development of HS235, a Potential Best-in-Class Investigational Medicine for Pulmonary Hypertension (PH)

GlobeNewsWire

MONTREAL, Feb. 25, 2026 (GLOBE NEWSWIRE) -- 35Pharma, a Canada-based, private, clinical-stage biopharmaceutical company specialised in the development of novel protein-based therapeutics today announced it has entered into an agreement with GSK plc (GSK), under which GSK will acquire all of the outstanding equity interests in 35Pharma. The acquisition includes HS235, a potential best-in-class investigational medicine that has completed phase I healthy volunteer clinical trials with studies to start imminently in pulmonary arterial hypertension (PAH) and pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF).

Read full article arrow
News Thumbnail
5:00 PM | Thursday | Feb 12, 2026

Parker Scheduled to Present at Citi's 2026 Global Industrial Tech and Mobility Conference on February 19 at 11:20 a.m. Eastern Time

GlobeNewsWire

CLEVELAND, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that it is scheduled to present at Citi's 2026 Global Industrial Tech and Mobility Conference in Miami, Florida on February 19, 2026 at 11:20 a.m. Eastern time.

Read full article arrow
News Thumbnail
5:10 PM | Wednesday | Feb 11, 2026

Parker Scheduled to Present at the Barclays 43rd Industrial Select Conference on February 18 at 11:00 a.m. Eastern Time

GlobeNewsWire

CLEVELAND, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that it is scheduled to present at the Barclays 43rd Industrial Select Conference in Miami Beach, Florida on February 18, 2026 at 11:00 a.m. Eastern time. A live webcast of the presentation will be accessible on Parker's investor information website at investors.
parker.com and will be archived on the site.

Read full article arrow
News Thumbnail
9:00 AM | Monday | Feb 9, 2026

Parker's Fiscal Year 2025 Sustainability Report Demonstrates Purpose in Motion

GlobeNewsWire

CLEVELAND, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, has released its fiscal year 2025 Sustainability Report. Themed “Purpose in Motion,” the report highlights how Parker's team members bring to life its purpose statement, Enabling Engineering Breakthroughs that Lead to a Better Tomorrow.

Read full article arrow
News Thumbnail